[A case of refractory acute lymphocytic leukemia responded to an intermediate-dose of cytosine arabinoside (ID Ara-C) therapy].
Hirota
Y
Y
Shibuya
T
T
Ohhara
N
N
Okamura
S
S
Iwagiri
R
R
Tada
Y
Y
Otsuka
T
T
Nagano
M
M
Tsuda
Y
Y
Niho
Y
Y
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004351:Drug Resistance; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D003561:Cytarabine